February 2025 | AIChE

Other Sites & Tools

Technical Groups

You are here

February 2025

Charles (Chuck) Murry

Dr. Charles (Chuck) Murry received his bachelor’s degree in chemistry from the University of North Dakota, followed by MD-PhD training at Duke University, where he studied myocardial ischemia-reperfusion injury (heart attacks). He did residency training in Pathology at the University of Washington, followed by fellowship training in vascular biology and diagnostic cardiovascular pathology.  

Murry completed his 28 years as a professor with tenure in the departments of Laboratory Medicine & Pathology, Bioengineering, and Medicine/Cardiology at the University of...Read more

Ketjen

Michael Coolbaugh

Michael joined the purification process development team at Sanofi in 2014 after receiving his PhD in Chemical and Biomolecular Engineering from Ohio State. Since joining Sanofi, he has led purification, drug substance, and CMC teams for a variety of molecules in Sanofi’s pipeline, ranging from monoclonal antibodies to enzyme replacement therapies for both early clinical and late-stage commercial programs. Michael has also been very active in Sanofi’s integrated continuous biomanufacturing (ICB) technology development efforts and is currently leading Sanofi’...Read more

Sherry Gu

With over 27 years of biopharmaceutical industry experience, WuXi Biologics’ Executive Vice President and Chief Technology Officer, Dr. Sherry Gu has established extensive expertise in cell line, upstream and downstream development and portfolio management while in her various roles at WuXi Biologics and in her well-established career in the biopharmaceutical industry.  Dr Sherry Gu joined WuXi Biologics in 2017 and built a strong CMC team in the U.S. & EU. She was instrumental in establishing WuXi Biologics’ global footprint and business growth by...Read more

Adithya Balasubramanian

With 15+ years in biotech, including roles at Regeneron, Genentech, and Lonza, Adi is a Scientist-turned-Business Development Director at ten23 health. He specializes in external collaborations, alliance management, and formulation development, particularly for antibody-drug conjugates (ADCs). Adi drives new business and provides strategic guidance to R&D teams.

Adi began his career at Regeneron and Genentech, contributing to therapies like Eylea® and Polivy®. He played a key role in establishing...Read more

Elçin Içten-Gençer

Dr. Elçin Içten-Gençer is an Associate Director of Data Sciences in Transformative Digital Capabilities at Amgen, where she leads a team focused on AI and Machine Learning Digital Twins for process development. With a background spanning synthetics, biologics, and drug product technologies, she has led digital innovation in biopharmaceutical process development, enhancing efficiency, control, and predictive capabilities across drug development pipelines.

Elçin holds a Ph.D. in Chemical Engineering from Purdue University...Read more

Elçin Içten-Gençer

Dr. Elçin Içten-Gençer is an Associate Director of Data Sciences in Transformative Digital Capabilities at Amgen, where she leads a team focused on AI and Machine Learning Digital Twins for process development. With a background spanning synthetics, biologics, and drug product technologies, she has led digital innovation in biopharmaceutical process development, enhancing efficiency, control, and predictive capabilities across drug development pipelines.

Elçin holds a Ph.D. in Chemical Engineering from Purdue University...Read more

Elçin Içten-Gençer

Dr. Elçin Içten-Gençer is an Associate Director of Data Sciences in Transformative Digital Capabilities at Amgen, where she leads a team focused on AI and Machine Learning Digital Twins for process development. With a background spanning synthetics, biologics, and drug product technologies, she has led digital innovation in biopharmaceutical process development, enhancing efficiency, control, and predictive capabilities across drug development pipelines.

Elçin holds a Ph.D. in Chemical Engineering from Purdue University...Read more

Elçin Içten-Gençer

Dr. Elçin Içten-Gençer is an Associate Director of Data Sciences in Transformative Digital Capabilities at Amgen, where she leads a team focused on AI and Machine Learning Digital Twins for process development. With a background spanning synthetics, biologics, and drug product technologies, she has led digital innovation in biopharmaceutical process development, enhancing efficiency, control, and predictive capabilities across drug development pipelines.

Elçin holds a Ph.D. in Chemical Engineering from Purdue University...Read more

Vinod Bulusu

Vinod Bulusu leads Products team in Global Technical Operations (GTO) and provides CMC leadership in Operations for all biologics modalities at AstraZeneca. Vinod, has about 20 years’ experience in commercializing biologics. Prior to AstraZeneca, Vinod worked at PwC as a management consultant and at Amgen leading late stage process development and technology transfers. Vinod has a Masters in Chemical Engineering and an MBA. Read more

Pages